FDA News in Review: September 2008

fda.sp.png

Today we're kicking off our first installment of "FDA News in Review," where each month we'll take a look at the agency's latest decision, approvals, warnings and recalls. We hope this feature will help you keep up on FDA trends--and catch up on stories you may have missed. One of the biggest stories out of the FDA this month was the agency's major hiring push, which will result many chemists, biologists and microbiologists being added to the FDA's ranks. Drug safety was also in the spotlight in September, as the agency announced that it will now release a quarterly list of drugs under investigation due to adverse events. Feature

Suggested Articles

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.

With two more former Insys executives facing prison time, another is claiming sexist hiring as an excuse for her role in a kickback scheme.